This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Analysts' Actions: COF QCOM DECK HOT ESRX

Analog Devices target raised at Jefferies to $51, Jefferies said. Improving order rates. Hold rating.

BJ's Restaurants (BJRI) numbers lowered at Oppenheimer. Shares of BJRI now seen reaching $38, Oppenheimer said. Estimates also lowered as model remains challenged. Outperform rating.

Bruker (BRKR) numbers raised at UBS. Shares of BRKR now seen reaching $21, UBS said. Estimates also increased on double digit organic growth and EPS beat in 4Q. Buy rating.

Conagra (CAG) estimates, target raised at Credit Suisse. Shares of CAG now seen reaching $36, according to Credit Suisse. Estimates also increased, as the company is carrying a lot of momentum into 2013. Neutral rating.

Chemed Corporation (CHE) target raised at Oppenheimer to $91, Oppenheimer said. Fourth quarter beat. Outperform rating.

Express Scripts (ESRX - Get Report) numbers boosted at Lazard. Shares of ESRX now seen reaching $65, according to Lazard Capital Markets. Estimates also upped, given better operating trends. Buy rating.

Express estimates, target boosted at Wedbush. Shares of EXPR now seen reaching $22, according to Wedbush. Estimates also upped, given positive early checks on the Spring season. Outperform rating.

First Solar (FSLR) numbers raised at UBS. Shares of FSLR now seen reaching $36, UBS said. Estimates also increased on expected guide up for 2013 on higher margins. Neutral rating.

Medtronic (MDT) estimates, target increased at BMO. MDT estimates were raised through 2015, BMO Capital said. Company continues to grow across the board. Outperform rating and new $52 price target.

Omnicare (OCR) estimates, target upped at JP Morgan. OCR estimates were boosted through 2014, JP Morgan said. Company raised its guidance. Overweight rating and new $45 price target.

Qualcomm (QCOM - Get Report) added to Conviction Buy List at Nomura. QCOM was placed on the US Conviction Buy list, according to Nomura. Company is a market leader and should see improving traction in China. $75 price target.

Realogy (RLGY) estimates, target raised at JP Morgan. Shares of RLGY now seen reaching $51, according to JP Morgan. Estimates also increased, given better business trends. Overweight rating.

Sealed Air (SEE) numbers raised at Jefferies. Shares of SEE now seen reaching $25, Jefferies said. Estimates also raised on hard stance on pricing and restructuring underway. Buy rating.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
COF $79.15 0.00%
DECK $74.52 0.00%
ESRX $84.93 0.00%
HOT $82.86 0.00%
QCOM $72.66 0.00%

Markets

DOW 18,288.63 +155.93 0.86%
S&P 500 2,117.39 +12.89 0.61%
NASDAQ 5,008.0960 +44.5690 0.90%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs